Interestingly, there was no functional data showing the role of SIRP in B cells, while SIRPα was reported to be a critical regulator of myeloid cell activation via binding to CD47 and SIRPα/CD47 axis limited the efficacy of tumor-opsonising antibodies (214). The gene discussed is CD47; the disease is neoplasm.